Original news and analysis on international IP policy
Some three dozen global civil society groups have called on the G20 countries to set a digital agenda that puts the interests of people and their rights front and centre, in particular on privacy.
This week's meeting of the World Intellectual Property Organization copyright committee opened today with what officials perceived as good momentum. Argentina tabled a proposal to help discussions on deferred transmissions in the context of a potential treaty protecting broadcasting organisations, which have been a sticking point in negotiations. Civil society, however, voiced concerns on the provisions of a potential treaty protecting broadcasters against signal piracy, underlining the 50-year envisioned protection and the need to carve out strong limitations and exceptions.
The Medicines Patent Pool announced this week that its Board agreed on the extension of the MPP mandate to patented medicines on the World Health Organization Essential Medicines List. The decision follows an extensive feasibility study. During a side event held on the margins of the annual World Health Assembly, Patent Pool officials explained the findings of the study, while in the audience, a representative of the pharmaceutical industry suggested a cautious approach.
The World Intellectual Property Organization copyright committee this morning started its weeklong meeting by rubber-stamping three nongovernmental organisations as observers, without discussion.
But a look at the website, www.ipcentreug.org, of one of the groups, as provided in the WIPO document as approved, states that the mission of the group is a "global conspiracy investigation institution" whose mission is to "free individuals and organizations from space lizards' control."
It took nine years of policy development, two different draft policies and various rounds of public consultation, to finally see Cabinet give the nod to the new Intellectual Property (IP) policy in South Africa.
Some 90 percent of people in the world who need assistive technology – such as glasses, walkers, or hearing aids - cannot access it, with the worst deficiency in developing countries. Today, World Health Organization members agreed on a resolution to improve access to those technologies, with overwhelming support. The WHO is instructed to provide support to countries and prepare a global report by 2021. Member states are requested to promote innovation and find ways to reduce prices.
European Union member states today reportedly agreed on their negotiating position on the proposed copyright directive, and early reactions are unenthusiastic.
Ten years after the adoption of a World Health Organization plan of action meant to stimulate innovation for diseases that disproportionately affect developing countries, and with very little to show for it since, delegates at the World Health Assembly this week agreed to a number of recommendations to reinvigorate the effort. How to finance the implementation of those recommendations, however, is unclear.
On the side of this week’s World Health Assembly and hours before the Assembly agreed on preparing a roadmap on access to medicines, two civil society groups held an event on the same subject. The Brazilian ambassador, a senior official from the Netherlands, and a WHO assistant director general among others delivered their thoughts on the issue and the way forward. Key words were high prices, transparency, and trade flexibilities.
The World Health Assembly yesterday agreed on a roadmap to be designed by the World Health Organization in consultation with member states to facilitate access to medicines and vaccines, including actions and activities for the period 2019-2023. If everyone agrees access to medicines and vaccines is indispensable for universal health coverage, views are still divided when it comes to intellectual property rights. The ranks of strong proponents of IP resulting in high prices are however thinning. The United States remains unshakeable, criticising compulsory licences used by countries to ensure affordable medicines are available.